PharmaSGP Holding SE Market Cap ($331.56 Million)
Market Cap & Net Worth: PharmaSGP Holding SE (PSG)
PharmaSGP Holding SE market cap. PharmaSGP Holding SE (F:PSG) has a market capitalization of $331.56 Million (€283.60 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #14066 globally and #1438 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PharmaSGP Holding SE's stock price €28.80 by its total outstanding shares 11512500 (11.51 Million). Also see PSG operating cash flow for how efficiently the company converts equity into cash flow.
PharmaSGP Holding SE Market Cap History (2020–2025)
PharmaSGP Holding SE market cap history from 2020 to 2025. Data shows change from $306.70 Million to $387.63 Million (-2.21% CAGR). Check PharmaSGP Holding SE (PSG) share price today for real-time trading data and today's change.
PharmaSGP Holding SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PharmaSGP Holding SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PSG year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.74x
PharmaSGP Holding SE's market cap is 2.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
16.67x
PharmaSGP Holding SE's market cap is 16.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $306.70 Million | $63.25 Million | $10.64 Million | 4.85x | 28.82x |
| 2021 | $303.03 Million | $65.34 Million | $10.69 Million | 4.64x | 28.35x |
| 2022 | $312.48 Million | $85.82 Million | $11.95 Million | 3.64x | 26.14x |
| 2023 | $273.82 Million | $101.10 Million | $16.40 Million | 2.71x | 16.70x |
| 2024 | $325.72 Million | $118.84 Million | $19.54 Million | 2.74x | 16.67x |
Competitor Companies of PSG by Market Capitalization
Companies near PharmaSGP Holding SE in the global market cap rankings as of November 4, 2026. Also see PharmaSGP Holding SE balance sheet assets for a full breakdown of the balance sheet.
Key companies related to PharmaSGP Holding SE by market ranking:
- Esso (Thailand) Public Company Limited (BK:BSRC): Ranked #14057 globally with a market cap of $332.25 Million USD ( ฿10.66 Billion THB).
- Lowland Investment Co (LSE:LWI): Ranked #14058 globally with a market cap of $332.16 Million USD ( £247.34 Million GBP).
- Paz Corp (SN:PAZ): Ranked #14067 globally with a market cap of $331.54 Million USD ( CL$296.46 Billion CLP).
- Fullink Technology Co. LTD. (SHE:301067): Ranked #14068 globally with a market cap of $331.53 Million USD ( CN¥2.27 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #14057 | Esso (Thailand) Public Company Limited | BK:BSRC | $332.25 Million | ฿3.08 |
| #14058 | Lowland Investment Co | LSE:LWI | $332.16 Million | £188.50 |
| #14067 | Paz Corp | SN:PAZ | $331.54 Million | CL$1046.20 |
| #14068 | Fullink Technology Co. LTD. | SHE:301067 | $331.53 Million | CN¥23.30 |
Market Capitalization of PharmaSGP Holding SE (2020–2025)
Market capitalization of PharmaSGP Holding SE from 2020 to today. Between 2020 and today, PharmaSGP Holding SE's market cap moved from $306.70 Million to $ 387.63 Million, with a yearly change of -2.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €387.63 Million | +19.01% |
| 2024 | €325.72 Million | +18.95% |
| 2023 | €273.82 Million | -12.37% |
| 2022 | €312.48 Million | +3.12% |
| 2021 | €303.03 Million | -1.19% |
| 2020 | €306.70 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 10th, 2026 the market cap of PharmaSGP Holding SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.56 Million USD |
| MoneyControl | $331.56 Million USD |
| MarketWatch | $331.56 Million USD |
| marketcap.company | $331.56 Million USD |
| Reuters | $331.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PharmaSGP Holding SE
PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil … Read more